Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023

Upgrades

According to RBC Capital, the prior rating for Montrose Environmental Group Inc MEG was changed from Sector Perform to Outperform. In the second quarter, Montrose Environmental Gr showed an EPS of $0.13, compared to $0.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $55.00 and a 52-week-low of $26.64. Montrose Environmental Gr closed at $27.76 at the end of the last trading period.

For Ameris Bancorp ABCB, DA Davidson upgraded the previous rating of Neutral to Buy. For the second quarter, Ameris had an EPS of $0.91, compared to year-ago quarter EPS of $1.18. The stock has a 52-week-high of $54.17 and a 52-week-low of $28.33. At the end of the last trading period, Ameris closed at $38.22.

According to B of A Securities, the prior rating for Sabra Health Care REIT Inc SBRA was changed from Neutral to Buy. For the second quarter, Sabra Health Care REIT had an EPS of $0.33, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $14.32 and a 52-week-low of $10.08. Sabra Health Care REIT closed at $14.01 at the end of the last trading period.

According to B of A Securities, the prior rating for Omega Healthcare Investors Inc OHI was changed from Neutral to Buy. Omega Healthcare Invts earned $0.74 in the second quarter, compared to $0.76 in the year-ago quarter. The stock has a 52-week-high of $34.13 and a 52-week-low of $25.61. At the end of the last trading period, Omega Healthcare Invts closed at $33.64.

B of A Securities upgraded the previous rating for Electronic Arts Inc EA from Neutral to Buy. For the first quarter, Electronic Arts had an EPS of $1.14, compared to year-ago quarter EPS of $0.47. The current stock performance of Electronic Arts shows a 52-week-high of $140.30 and a 52-week-low of $108.53. Moreover, at the end of the last trading period, the closing price was at $124.59.

Piper Sandler upgraded the previous rating for Exact Sciences Corp EXAS from Neutral to Overweight. In the second quarter, Exact Sciences showed an EPS of $0.45, compared to $0.90 from the year-ago quarter. The stock has a 52-week-high of $100.77 and a 52-week-low of $29.29. At the end of the last trading period, Exact Sciences closed at $64.46.

Jefferies upgraded the previous rating for Pinnacle Financial Partners Inc PNFP from Underperform to Hold. In the second quarter, Pinnacle Finl Partners showed an EPS of $1.79, compared to $1.86 from the year-ago quarter. The stock has a 52-week-high of $89.00 and a 52-week-low of $43.31. At the end of the last trading period, Pinnacle Finl Partners closed at $66.25.

For ACADIA Pharmaceuticals Inc ACAD, JP Morgan upgraded the previous rating of Neutral to Overweight. In the second quarter, ACADIA Pharmaceuticals showed an EPS of $0.01, compared to $0.21 from the year-ago quarter. The current stock performance of ACADIA Pharmaceuticals shows a 52-week-high of $33.99 and a 52-week-low of $13.73. Moreover, at the end of the last trading period, the closing price was at $21.74.

According to UBS, the prior rating for Rivian Automotive Inc RIVN was changed from Neutral to Buy. In the second quarter, Rivian Automotive showed an EPS of $1.08, compared to $1.62 from the year-ago quarter. At the moment, the stock has a 52-week-high of $36.44 and a 52-week-low of $11.68. Rivian Automotive closed at $18.78 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

According to Barrington Research, the prior rating for StarTek Inc SRT was changed from Outperform to Market Perform. For the second quarter, StarTek had an EPS of $0.04, compared to year-ago quarter EPS of $0.13. The current stock performance of StarTek shows a 52-week-high of $4.53 and a 52-week-low of $2.64. Moreover, at the end of the last trading period, the closing price was at $3.26.

For Netstreit Corp NTST, B of A Securities downgraded the previous rating of Neutral to Underperform. In the second quarter, Netstreit showed an EPS of $0.30, compared to $0.28 from the year-ago quarter. The current stock performance of Netstreit shows a 52-week-high of $20.64 and a 52-week-low of $14.84. Moreover, at the end of the last trading period, the closing price was at $15.20.

For Spirit Realty Capital Inc SRC, B of A Securities downgraded the previous rating of Neutral to Underperform. Spirit Realty Cap earned $0.91 in the second quarter, compared to $0.90 in the year-ago quarter. The stock has a 52-week-high of $44.65 and a 52-week-low of $32.48. At the end of the last trading period, Spirit Realty Cap closed at $33.59.

For Realty Income Corp O, B of A Securities downgraded the previous rating of Buy to Neutral. For the second quarter, Realty Income had an EPS of $1.00, compared to year-ago quarter EPS of $0.97. The stock has a 52-week-high of $68.85 and a 52-week-low of $48.41. At the end of the last trading period, Realty Income closed at $50.55.

According to Citigroup, the prior rating for Skyworks Solutions Inc SWKS was changed from Neutral to Sell. Skyworks Solutions earned $1.73 in the third quarter, compared to $2.44 in the year-ago quarter. The stock has a 52-week-high of $123.69 and a 52-week-low of $76.17. At the end of the last trading period, Skyworks Solutions closed at $98.22.

According to Citigroup, the prior rating for Qorvo Inc QRVO was changed from Neutral to Sell. For the first quarter, Qorvo had an EPS of $0.34, compared to year-ago quarter EPS of $2.25. The current stock performance of Qorvo shows a 52-week-high of $114.59 and a 52-week-low of $75.58. Moreover, at the end of the last trading period, the closing price was at $94.90.

UBS downgraded the previous rating for NextEra Energy Partners LP NEP from Buy to Neutral. NextEra Energy Partners earned $0.53 in the second quarter, compared to $2.61 in the year-ago quarter. The stock has a 52-week-high of $81.07 and a 52-week-low of $20.17. At the end of the last trading period, NextEra Energy Partners closed at $20.58.

For Euronav NV EURN, Citigroup downgraded the previous rating of Buy to Neutral. For the second quarter, Euronav had an EPS of $0.80, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $21.00 and a 52-week-low of $12.94. At the end of the last trading period, Euronav closed at $17.69.

Piper Sandler downgraded the previous rating for Mirati Therapeutics Inc MRTX from Overweight to Neutral. For the second quarter, Mirati Therapeutics had an EPS of $3.04, compared to year-ago quarter EPS of $3.18. The stock has a 52-week-high of $101.20 and a 52-week-low of $27.30. At the end of the last trading period, Mirati Therapeutics closed at $57.02.

Stifel downgraded the previous rating for Euronav NV EURN from Buy to Hold. In the second quarter, Euronav showed an EPS of $0.80, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $21.00 and a 52-week-low of $12.94. Euronav closed at $17.69 at the end of the last trading period.

According to JP Morgan, the prior rating for Juniper Networks Inc JNPR was changed from Overweight to Neutral. For the second quarter, Juniper Networks had an EPS of $0.58, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $34.53 and a 52-week-low of $25.18. At the end of the last trading period, Juniper Networks closed at $26.82.

According to Keefe, Bruyette & Woods, the prior rating for Starwood Property Trust Inc STWD was changed from Outperform to Market Perform. In the second quarter, Starwood Prop Trust showed an EPS of $0.49, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $21.73 and a 52-week-low of $16.06. At the end of the last trading period, Starwood Prop Trust closed at $19.05.

JP Morgan downgraded the previous rating for Corning Inc GLW from Overweight to Neutral. Corning earned $0.45 in the second quarter, compared to $0.57 in the year-ago quarter. The current stock performance of Corning shows a 52-week-high of $37.10 and a 52-week-low of $29.17. Moreover, at the end of the last trading period, the closing price was at $29.44.

See all analyst ratings downgrades.

Initiations

With a Buy rating, Ladenburg Thalmann initiated coverage on Zura Bio Ltd ZURA. The price target seems to have been set at $10.00 for Zura Bio. Zura Bio earned $1.31 in the second quarter, compared to $9.54 in the year-ago quarter. The current stock performance of Zura Bio shows a 52-week-high of $37.55 and a 52-week-low of $4.87. Moreover, at the end of the last trading period, the closing price was at $6.93.

With an Overweight rating, JP Morgan initiated coverage on Neumora Therapeutics Inc NMRA. The price target seems to have been set at $21.00 for Neumora Therapeutics. At the moment, the stock has a 52-week-high of $17.74 and a 52-week-low of $9.90. Neumora Therapeutics closed at $11.94 at the end of the last trading period.

Scotiabank initiated coverage on MongoDB Inc MDB with a Sector Perform rating. The price target for MongoDB is set to $335.00. In the second quarter, MongoDB showed an EPS of $0.93, compared to $0.23 from the year-ago quarter. The current stock performance of MongoDB shows a 52-week-high of $439.00 and a 52-week-low of $135.17. Moreover, at the end of the last trading period, the closing price was at $358.31.

Truist Securities initiated coverage on Blackstone Secured Lending Fund BXSL with a Buy rating. The price target for Blackstone Secured is set to $29.00. For the second quarter, Blackstone Secured had an EPS of $1.06, compared to year-ago quarter EPS of $0.62. At the moment, the stock has a 52-week-high of $29.11 and a 52-week-low of $22.08. Blackstone Secured closed at $26.43 at the end of the last trading period.

With a Buy rating, B of A Securities initiated coverage on Neumora Therapeutics Inc NMRA. The price target seems to have been set at $18.00 for Neumora Therapeutics. At the moment, the stock has a 52-week-high of $17.74 and a 52-week-low of $9.90. Neumora Therapeutics closed at $11.94 at the end of the last trading period.

With a Buy rating, Truist Securities initiated coverage on RayzeBio inc RYZB. The price target seems to have been set at $29.00 for RayzeBio. The stock has a 52-week-high of $26.00 and a 52-week-low of $17.95. At the end of the last trading period, RayzeBio closed at $21.03.

With a Neutral rating, B of A Securities initiated coverage on Popular Inc BPOP. The price target seems to have been set at $63.00 for Popular. In the second quarter, Popular showed an EPS of $2.10, compared to $2.77 from the year-ago quarter. The current stock performance of Popular shows a 52-week-high of $77.36 and a 52-week-low of $49.34. Moreover, at the end of the last trading period, the closing price was at $64.13.

With a Neutral rating, Compass Point initiated coverage on Equity Lifestyle Properties Inc ELS. The price target seems to have been set at $65.00 for Equity Lifestyle Props. Equity Lifestyle Props earned $0.66 in the second quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $74.40 and a 52-week-low of $57.01. Equity Lifestyle Props closed at $64.03 at the end of the last trading period.

Exane BNP Paribas initiated coverage on Dollar General Corp DG with a Neutral rating. The price target for Dollar Gen is set to $116.00. In the second quarter, Dollar Gen showed an EPS of $2.13, compared to $2.98 from the year-ago quarter. The current stock performance of Dollar Gen shows a 52-week-high of $261.57 and a 52-week-low of $101.98. Moreover, at the end of the last trading period, the closing price was at $102.00.

Exane BNP Paribas initiated coverage on Dollar Tree Inc DLTR with an Outperform rating. The price target for Dollar Tree is set to $139.00. In the second quarter, Dollar Tree showed an EPS of $0.91, compared to $1.60 from the year-ago quarter. The stock has a 52-week-high of $170.36 and a 52-week-low of $102.77. At the end of the last trading period, Dollar Tree closed at $104.71.

For Neumora Therapeutics Inc NMRA, William Blair initiated coverage, by setting the current rating at Outperform. The stock has a 52-week-high of $17.74 and a 52-week-low of $9.90. At the end of the last trading period, Neumora Therapeutics closed at $11.94.

With a Buy rating, Daiwa Capital initiated coverage on ARM Holdings PLC ARM. The price target seems to have been set at $63.00 for ARM Holdings. The stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. At the end of the last trading period, ARM Holdings closed at $54.25.

With a Buy rating, Guggenheim initiated coverage on Neumora Therapeutics Inc NMRA. The price target seems to have been set at $22.00 for Neumora Therapeutics. The current stock performance of Neumora Therapeutics shows a 52-week-high of $17.74 and a 52-week-low of $9.90. Moreover, at the end of the last trading period, the closing price was at $11.94.

With an Outperform rating, RBC Capital initiated coverage on Neumora Therapeutics Inc NMRA. The price target seems to have been set at $24.00 for Neumora Therapeutics. The stock has a 52-week-high of $17.74 and a 52-week-low of $9.90. At the end of the last trading period, Neumora Therapeutics closed at $11.94.

JP Morgan initiated coverage on RayzeBio inc RYZB with an Overweight rating. The price target for RayzeBio is set to $30.00. The stock has a 52-week-high of $26.00 and a 52-week-low of $17.95. At the end of the last trading period, RayzeBio closed at $21.03.

With a Buy rating, Jefferies initiated coverage on RayzeBio inc RYZB. The price target seems to have been set at $35.00 for RayzeBio. The stock has a 52-week-high of $26.00 and a 52-week-low of $17.95. At the end of the last trading period, RayzeBio closed at $21.03.

Stifel initiated coverage on Neumora Therapeutics Inc NMRA with a Buy rating. The price target for Neumora Therapeutics is set to $26.00. The stock has a 52-week-high of $17.74 and a 52-week-low of $9.90. At the end of the last trading period, Neumora Therapeutics closed at $11.94.

With a Buy rating, Societe Generale initiated coverage on SLB SLB. The price target seems to have been set at $81.00 for SLB. SLB earned $0.72 in the second quarter, compared to $0.50 in the year-ago quarter. The current stock performance of SLB shows a 52-week-high of $62.78 and a 52-week-low of $41.10. Moreover, at the end of the last trading period, the closing price was at $58.24.

With an Outperform rating, Wedbush initiated coverage on MannKind Corp MNKD. The price target seems to have been set at $10.00 for MannKind. For the second quarter, MannKind had an EPS of $0.00, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $5.75 and a 52-week-low of $2.91. At the end of the last trading period, MannKind closed at $3.94.

With a Market Perform rating, TD Cowen initiated coverage on Advance Auto Parts Inc AAP. The price target seems to have been set at $55.00 for Advance Auto Parts. Advance Auto Parts earned $1.43 in the second quarter, compared to $3.74 in the year-ago quarter. The stock has a 52-week-high of $194.23 and a 52-week-low of $50.14. At the end of the last trading period, Advance Auto Parts closed at $51.36.

TD Cowen initiated coverage on AutoZone Inc AZO with an Outperform rating. The price target for AutoZone is set to $2975.00. In the fourth quarter, AutoZone showed an EPS of $46.46, compared to $40.51 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2750.00 and a 52-week-low of $2165.93. AutoZone closed at $2564.93 at the end of the last trading period.

TD Cowen initiated coverage on O'Reilly Automotive Inc ORLY with an Outperform rating. The price target for O'Reilly Automotive is set to $1100.00. For the second quarter, O'Reilly Automotive had an EPS of $10.22, compared to year-ago quarter EPS of $8.78. At the moment, the stock has a 52-week-high of $975.72 and a 52-week-low of $705.74. O'Reilly Automotive closed at $914.67 at the end of the last trading period.

See all analyst ratings initiations.